SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-177015
Filing Date
2024-07-10
Accepted
2024-07-10 08:14:05
Documents
17
Period of Report
2024-07-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d846136d8k.htm   iXBRL 8-K 48259
2 EX-2.1 d846136dex21.htm EX-2.1 633763
3 EX-99.1 d846136dex991.htm EX-99.1 17117
8 GRAPHIC g846136g0709211730547.jpg GRAPHIC 3118
  Complete submission text file 0001193125-24-177015.txt   1034990

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA prgo-20240703.xsd EX-101.SCH 5131
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prgo-20240703_def.xml EX-101.DEF 15078
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE prgo-20240703_lab.xml EX-101.LAB 25566
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prgo-20240703_pre.xml EX-101.PRE 16306
20 EXTRACTED XBRL INSTANCE DOCUMENT d846136d8k_htm.xml XML 10401
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36353 | Film No.: 241108726
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)